Sign in

Doris Molina-Henry

@dorismolinahen.bsky.social
54 followers 110 following 4 posts

Neurobiologist and emerging AD clinical trialist focused on recruitment and retention science. Interested in differences in AD biomarkers across demographic subpopulations. #impactAD2020

PostsRepliesMedia
Doris Molina-Henry @dorismolinahen.bsky.social · 28/11/2024
Excited to share that I’ll be participating in the Equity by Design Panel at the Societal Implications of Geroscience Workshop, hosted by the National Academy of Medicine on Dec 5, 2024! Looking forward to discussing how geroscience impacts aging and society. #Geroscience #HealthyAging
nam.edu
Societal Implications of Geroscience: A Workshop - National Academy of Medicine
Date & Time: December 5, 2024 9:00 AM – 4:30 PM ET Location: In Person & Virtual AARP National Office 601 E St NW, Washington, DC 20049 Register By: In […]
000
Doris Molina-Henry @dorismolinahen.bsky.social · 21/11/2024
Our work, along with that of other outstanding research teams presented at CTAD 2024 in Madrid, is featured on Alzforum! We must address the underlying drivers of dementia in understudied groups. Grateful for the incredible progress being made, thanks to the terrific advances in biomarkers!
alzforum.org
Biomarkers Suggest Black and Hispanic People Less Likely to Have Amyloid | ALZFORUM
000
Reposted by Doris Molina-Henry
Crystal M. Glover, Ph.D. @cgster.bsky.social · 18/11/2024
Another cool write up focused on our recently published guidelines regarding equitable study design and partnering with communities in dementia research. @sarahmwalter.bsky.social www.healio.com/news/psychia...
healio.com
Contact the Newsroom
02311
Doris Molina-Henry @dorismolinahen.bsky.social · 19/11/2024
I am #ALZFunded! #ENDALZ.
051